Johnson & Johnson Vision and The Eye Hospital of Wenzhou Medical University Announce Strategic Collaboration to Advance Myopia Control in Children and Adolescents

Johnson & Johnson Boosts Myopia Prevention and Control in Children and Adolescents

During the “2019 International Forum on Innovative Development in Visual Health,” Johnson & Johnson Vision and the Eye Hospital of Wenzhou Medical University held a signing ceremony for their strategic cooperation in visual science in Qingdao. Both parties actively responded to national directives on myopia prevention among children and adolescents, leveraged their respective strengths, and embarked on a new chapter of long-term strategic collaboration in myopia control and prevention for this population. Attending the signing ceremony were Professor Qu Jia, Dean of the Eye Hospital of Wenzhou Medical University; Professor Chen Hao, Deputy Dean of the Eye Hospital of Wenzhou Medical University; and Ms. Jin Xiqing, General Manager of Johnson & Johnson Vision China.

Johnson & Johnson Vision Signs Strategic Cooperation Agreement on Visual Science with the Eye Hospital of Wenzhou Medical University

At the signing ceremony, Dr. Qu Jia, President of the Eye Hospital of Wenzhou Medical University, stated, “Myopia prevention and control is a national strategy; however, beyond advocacy and calls to action, it requires comprehensive engagement from all sectors of society. Today’s strategic cooperation signing marks a concrete step in translating these appeals into tangible actions. As a Fortune Global 500 company, Johnson & Johnson has made significant contributions in the fields of health and vision care. We appreciate Johnson & Johnson’s continued commitment to advancing myopia prevention and control.”

In recognition of Johnson & Johnson’s outstanding contributions to public science education on myopia prevention and control, Johnson & Johnson Vision was awarded the Science Popularization Cooperation Award by the Organizing Committee at the opening ceremony of the 2019 International Forum on Innovative Development in Visual Health. Ms. Jin Xiqing, General Manager of Johnson & Johnson Vision Care China, accepted the award on behalf of the company.

Ms. Jin Xiqing, General Manager of Johnson & Johnson Vision Care China, accepted the Science Popularization Cooperation Award on behalf of the company.

Ms. Jin Xiqing, General Manager of Johnson & Johnson Vision in China, stated, “Vision is one of humanity’s most precious senses; yet myopia alone affects approximately one-third of the global population. We are honored to continue our collaboration with the Eye Hospital of Wenzhou Medical University and the Engineering Research Center for Myopia Prevention, Control, Diagnosis, and Treatment under the Ministry of Education, working together to meet patients’ eye health needs, advance myopia prevention and control among adolescents, and further contribute to the Healthy China initiative. Johnson & Johnson Vision remains committed to promoting eye health education and enhancing professional standards within the industry. Our vision is to help people see more clearly, communicate more effectively, and live better lives.”

Ms. Jin Xiqing, General Manager of Johnson & Johnson Vision Care China, delivered a speech.

According to the latest data released by the National Health Commission, the overall myopia rate among children and adolescents in China was 53.6% in 2018, indicating that the task of preventing and controlling myopia is arduous. In 2018, the state emphasized that all sectors of society must take action to jointly protect children’s eyesight and ensure they have a bright future. In August of the same year, the Ministry of Education and seven other departments issued the Implementation Plan for Comprehensive Prevention and Control of Myopia in Children and Adolescents, which clearly stated that by 2023, efforts should be made to reduce the national overall myopia rate among children and adolescents by more than 0.5 percentage points annually from the 2018 level, with high-prevalence provinces achieving an annual reduction of more than 1 percentage point.

The collaboration between Johnson & Johnson Vision and Wenzhou Medical University dates back more than a decade. In 2017, the two parties signed a letter of intent for strategic cooperation in vision science in New Orleans, establishing the “Wenzhou Medical University–Johnson & Johnson Vision Joint Research Center” to jointly advance scientific research, academic exchange, professional training and talent development, and public education on eye health in optometry and ophthalmology, achieving positive results.

The strategic partnership between Johnson & Johnson Vision and the Eye Hospital of Wenzhou Medical University not only continues their collaboration in professional education and talent development in optometry and ophthalmology but also places a strong emphasis on myopia prevention and control among children and adolescents. Leveraging the Engineering Research Center for Myopia Prevention, Control, and Treatment under the Ministry of Education, both parties will focus on developing functional science-education courseware and practical tools tailored to the Chinese context, and fully support public education campaigns on myopia prevention for children and adolescents. Over the next two years, the two organizations will launch a series of science popularization and public education initiatives. These include the joint development of educational courseware and tools on myopia prevention and control designed for various audiences (students, parents, and teachers), including but not limited to printed materials, digital courses, science-communication software, and self-assessment tools. They will also support the National Expert Lecture Team for Comprehensive Myopia Prevention and Control in Children and Adolescents in carrying out diverse online and offline science-communication and public-education activities. This strategic partnership between Johnson & Johnson Vision and the Eye Hospital of Wenzhou Medical University marks a new milestone in myopia prevention and control for children and adolescents.

For many years, Johnson & Johnson has continuously pioneered innovations to serve the health and well-being of patients and consumers. In the field of eye health, Johnson & Johnson Vision has been committed to helping more people improve and restore their vision. Through continuous innovation and research and development, it delivers clear and comfortable visual experiences to users. Upholding the philosophy of bringing healthy vision to everyone, everywhere, every day, Johnson & Johnson Vision continually introduces world-leading technologies and innovative products. It is dedicated to providing consumers with convenient, beautiful, healthy, and comfortable visual experiences, along with professional eye health services, thereby establishing professional service standards and norms for the contact lens industry and enhancing the overall level of eye health across China.

About Johnson & Johnson

Johnson & Johnson, founded in 1886, is one of the most comprehensive and widely diversified healthcare companies in the world, with businesses spanning three major sectors: consumer health, pharmaceuticals, and medical devices. Headquartered in New Brunswick, New Jersey, USA, the company operates more than 260 subsidiaries across 60 countries and regions worldwide, employs over 130,000 people globally, and reported global revenue of $81.6 billion in 2018.

At Johnson & Johnson, we firmly believe that health is the foundation of vibrant lives, thriving communities, and continuous progress. For over 130 years, we have remained dedicated to advancing health and well-being, empowering people to stay healthy at every age and stage of life. Today, as a comprehensive, multinational healthcare enterprise with a broad global presence, we are committed to leveraging our extensive influence to promote human health and build a better society. We strive to improve the accessibility and affordability of medicines, foster healthier communities, and enable people around the world to enjoy physical and mental well-being within a healthy environment. By integrating compassion, science, and wisdom, we drive meaningful change in the advancement of human health.

In 1985, as one of the first multinational corporations to enter the Chinese market following the launch of China’s reform and opening-up policy, Johnson & Johnson established Xi’an Janssen Pharmaceutical Ltd. in China. Over the years, Johnson & Johnson has been committed to providing high-quality innovative products to meet the growing healthcare needs, promoting health for Chinese patients and consumers, and contributing to the Healthy China initiative. Today, Johnson & Johnson’s business in China spans three key sectors: consumer health, pharmaceuticals, and medical devices. Currently, Johnson & Johnson operates 16 subsidiaries in China, with approximately 10,000 employees across more than 90 cities, including Beijing, Shanghai, Guangzhou, Suzhou, and Xi’an. For more information about Johnson & Johnson, please visit https://www.jnj.com.cn/.

About Johnson & Johnson Vision

Through the operations of Johnson & Johnson Vision Care and Johnson & Johnson Surgical Vision, Johnson & Johnson Vision is dedicated to improving and restoring patients’ vision worldwide. Since launching the world’s first replacement-contact lens in 1987, Johnson & Johnson Vision Care has helped countless patients see the world around them more clearly through its globally leading ACUVUE® brand portfolio of contact lens products. In 2017, following Johnson & Johnson’s acquisition of Abbott’s medical optics business, Johnson & Johnson Vision expanded its operations into cataract surgery, laser refractive surgery (LASIK), and consumer eye health, further strengthening its commitment to eye care. Johnson & Johnson Vision serves more than 60 million patients across 103 countries every day, striving to help more people improve or restore their vision. With dual headquarters in Jacksonville, Florida, and Santa Ana, California, Johnson & Johnson Vision employs more than 10,000 people worldwide. For more information about Johnson & Johnson Vision, please visit www.jjvision.com or search for Johnson & Johnson Vision on LinkedIn.